- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Eve Gets Health Canada Approval for Use of Existing Infrastructure
Eve & Co announced Health Canada authorized its subsidiary Natural MedCo to use a previously constructed flowering room as a grow area and a packaging room as an operations area.
Eve & Co (TSXV:EVE) announced Health Canada authorized its subsidiary Natural MedCo to use a previously constructed flowering room as a grow area and a packaging room as an operations area.
As quoted in the press release:
With the addition of these approved areas, Eve & Co now has 220,000 [square feet] of licensed grow and operation areas. The Company expects harvesting to commence at its newly licensed second flowering room by late March 2019.
Natural MedCo Ltd. has also received authorization to commence sales of additional types of cannabis products, including fresh and dried cannabis, to provincially authorized retailers and distributors. Eve & Co is now authorized to sell a variety of cannabis products to provincially authorized retailers and distributors, including fresh and dried cannabis and cannabis plants, and to other licensed cultivators and processors on the B2B market, including fresh and dried cannabis, cannabis plants and cannabis oil.
“The addition of Flowering Room #2 will allow us to more than double our current production levels and to grow in our new, state of the art flowering room. Approval for Packaging Room #2 will allow us to start using our automated packaging line to efficiently and quickly fill orders in immediate packaging. The amendment to our sales license expands our market to not only other licensed producers but also to provincial distributors,” commented Melinda Rombouts, Eve & Co’s President and CEO.
Click here to read the full press release.
Source: globenewswire.com
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.